| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/24/2023 | 11.71% | Argus Research | $225 → $250 | Maintains | Buy |
| 07/31/2023 | 9.47% | Oppenheimer | → $245 | Reiterates | Outperform → Outperform |
| 07/28/2023 | 13.94% | Citigroup | $243 → $255 | Maintains | Buy |
| 07/19/2023 | -1.7% | Stifel | $214 → $220 | Maintains | Hold |
| 05/22/2023 | 5% | TD Cowen | $240 → $235 | Maintains | Outperform |
| 05/01/2023 | 9.47% | Oppenheimer | → $245 | Reiterates | → Outperform |
| 04/28/2023 | -10.63% | Mizuho | $227 → $200 | Maintains | Neutral |
| 04/28/2023 | 8.58% | RBC Capital | $252 → $243 | Maintains | Outperform |
| 04/28/2023 | 8.58% | Citigroup | $268 → $243 | Maintains | Buy |
| 04/28/2023 | 22.88% | Wells Fargo | $280 → $275 | Maintains | Overweight |
| 04/28/2023 | -1.7% | Bernstein | $225 → $220 | Maintains | Market Perform |
| 04/28/2023 | 2.77% | Baird | $255 → $230 | Maintains | Outperform |
| 04/24/2023 | 9.47% | Oppenheimer | $247 → $245 | Maintains | Outperform |
| 04/17/2023 | 9.92% | Stifel | $242 → $246 | Maintains | Hold |
| 02/02/2023 | 1.43% | Mizuho | $225 → $227 | Maintains | Neutral |
| 02/02/2023 | 10.37% | Oppenheimer | $245 → $247 | Maintains | Outperform |
| 02/02/2023 | 13.94% | Baird | $227 → $255 | Maintains | Outperform |
| 02/02/2023 | 19.75% | Citigroup | $273 → $268 | Maintains | Buy |
| 01/26/2023 | 9.47% | Oppenheimer | $235 → $245 | Maintains | Outperform |
| 01/20/2023 | 8.13% | Stifel | $241 → $242 | Maintains | Hold |
| 01/18/2023 | 11.71% | Morgan Stanley | $235 → $250 | Maintains | Overweight |
| 01/13/2023 | 0.54% | Mizuho | $208 → $225 | Maintains | Neutral |
| 12/09/2022 | 21.98% | Citigroup | $228 → $273 | Maintains | Buy |
| 10/27/2022 | -7.06% | Mizuho | $205 → $208 | Maintains | Neutral |
| 10/27/2022 | 18.41% | Wells Fargo | $260 → $265 | Maintains | Overweight |
| 10/27/2022 | 5% | Morgan Stanley | $225 → $235 | Maintains | Overweight |
| 10/11/2022 | -5.72% | Stifel | $213 → $211 | Maintains | Hold |
| 08/17/2022 | -1.7% | Bernstein | → $220 | Reinstates | → Market Perform |
| 08/01/2022 | -8.4% | Mizuho | $190 → $205 | Maintains | Neutral |
| 07/28/2022 | -2.14% | RBC Capital | $216 → $219 | Maintains | Outperform |
| 07/19/2022 | -10.63% | Loop Capital | $220 → $200 | Maintains | Hold |
| 07/18/2022 | -15.1% | Mizuho | $205 → $190 | Maintains | Neutral |
| 07/18/2022 | -16% | Stifel | $229 → $188 | Downgrades | Buy → Hold |
| 07/14/2022 | -3.93% | Oppenheimer | → $215 | Upgrades | Perform → Outperform |
| 06/09/2022 | 0.54% | Morgan Stanley | $250 → $225 | Maintains | Overweight |
| 04/28/2022 | 6.34% | RBC Capital | $234 → $238 | Maintains | Outperform |
| 04/28/2022 | 5% | Citigroup | $232 → $235 | Maintains | Buy |
| 04/28/2022 | -8.4% | Mizuho | $233 → $205 | Maintains | Neutral |
| 04/18/2022 | 3.22% | Stifel | $244 → $231 | Maintains | Buy |
| 03/09/2022 | — | Cowen & Co. | Upgrades | Market Perform → Outperform | |
| 01/11/2022 | 2.77% | Bernstein | → $230 | Initiates Coverage On | → Market Perform |
| 12/17/2021 | 4.11% | Mizuho | → $233 | Initiates Coverage On | → Neutral |
| 10/28/2021 | 13.49% | RBC Capital | $252 → $254 | Maintains | Outperform |
| 10/20/2021 | 9.92% | Citigroup | $240 → $246 | Upgrades | Neutral → Buy |
| 05/03/2021 | 13.94% | Rosenblatt | $225 → $255 | Maintains | Buy |
| 04/29/2021 | -8.4% | DA Davidson | $190 → $205 | Maintains | Neutral |
| 04/29/2021 | 16.18% | Wells Fargo | $240 → $260 | Maintains | Overweight |
| 04/29/2021 | 11.71% | Morgan Stanley | $230 → $250 | Maintains | Overweight |
| 04/20/2021 | 7.24% | Wells Fargo | $220 → $240 | Maintains | Overweight |
| 03/31/2021 | 2.77% | Morgan Stanley | → $230 | Initiates Coverage On | → Overweight |
| 02/05/2021 | 0.54% | Rosenblatt | $220 → $225 | Maintains | Buy |
| 01/14/2021 | -1.7% | Cowen & Co. | $200 → $220 | Downgrades | Outperform → Market Perform |
| 01/12/2021 | -1.7% | Rosenblatt | $205 → $220 | Maintains | Buy |
| 12/04/2020 | -8.4% | Rosenblatt | $200 → $205 | Maintains | Buy |
| 09/22/2020 | -10.63% | Rosenblatt | $178 → $200 | Maintains | Buy |
| 07/27/2020 | -20.46% | Rosenblatt | $172 → $178 | Maintains | Buy |
| 07/02/2020 | -23.15% | Rosenblatt | $170 → $172 | Maintains | Buy |
| 04/27/2020 | -20.46% | Wells Fargo | $160 → $178 | Maintains | Overweight |
| 04/27/2020 | -23.15% | Rosenblatt | $160 → $172 | Maintains | Buy |
| 04/24/2020 | -37.44% | DA Davidson | $145 → $140 | Maintains | Neutral |
| 04/08/2020 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral | |
| 03/31/2020 | -28.51% | Cowen & Co. | → $160 | Upgrades | Market Perform → Outperform |
| 03/16/2020 | -26.27% | Wells Fargo | $210 → $165 | Maintains | Overweight |
| 03/16/2020 | -28.95% | Stifel | $164 → $159 | Upgrades | Hold → Buy |
| 01/31/2020 | -22.25% | RBC Capital | $180 → $174 | Maintains | Outperform |
| 01/31/2020 | -20.46% | Baird | $180 → $178 | Maintains | Outperform |
| 01/30/2020 | — | Janney Montgomery Scott | Downgrades | Neutral → Sell | |
| 11/07/2019 | -17.34% | Rosenblatt | → $185 | Initiates Coverage On | → Buy |
| 10/31/2019 | -15.1% | Wells Fargo | $200 → $190 | Maintains | Outperform |
| 07/29/2019 | -27.61% | Stifel | $157 → $162 | Maintains | Hold |
| 07/15/2019 | -29.85% | Stifel | $153 → $157 | Maintains | Hold |
| 05/15/2019 | -19.57% | Berenberg | → $180 | Initiates Coverage On | → Buy |
| 04/16/2019 | -31.64% | Stifel | $129 → $153 | Maintains | Hold |
| 01/04/2019 | -34.76% | RBC Capital | $141 → $146 | Upgrades | Sector Perform → Outperform |
| 10/25/2018 | -37.89% | Baird | $145 → $139 | Maintains | Outperform |
| 10/25/2018 | -33.42% | Janney Montgomery Scott | → $149 | Upgrades | Neutral → Buy |
| 10/08/2018 | -32.98% | Stifel | $149 → $150 | Maintains | Hold |
What is the target price for IDEX (IEX)?
The latest price target for IDEX (NYSE: IEX) was reported by Argus Research on August 24, 2023. The analyst firm set a price target for $250.00 expecting IEX to rise to within 12 months (a possible 11.71% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IDEX (IEX)?
The latest analyst rating for IDEX (NYSE: IEX) was provided by Argus Research, and IDEX maintained their buy rating.
When is the next analyst rating going to be posted or updated for IDEX (IEX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IDEX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IDEX was filed on August 24, 2023 so you should expect the next rating to be made available sometime around August 24, 2024.
Is the Analyst Rating IDEX (IEX) correct?
While ratings are subjective and will change, the latest IDEX (IEX) rating was a maintained with a price target of $225.00 to $250.00. The current price IDEX (IEX) is trading at is $223.80, which is out of the analyst's predicted range.